Premiumization momentum real, but Q1 miss and H2 seasonality risk margin claims
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
First quarter of FY27 guidance track record; management reaffirmed Q4 guidance, margins improving only incrementally vs. prior promises
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Premiumization strategy gaining traction (47.3% branded alco-bev growth, 13th largest single malt globally), but Q1 result masks execution challenges: revenue growth modest at 18%, PAT growth only 16%, margins flat despite 30 bps EBITDA improvement. Guidance maintained (60-70% alco-bev, 23-24% EBITDA) is reaffirmation, not upgrade. H2 seasonality (60-65% of annual revenue) and cost inflation (grain, fuel, labor) create execution risk.
₹270.5 Cr
Revenue · +18.1% YoY₹21.4 Cr
Reported PAT · +16.3% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Q1 was landmark quarter with highest ever volumes
OVERSTATEDRevenue 270.5 Cr, YoY +18.1%, QoQ -24.8%; extreme seasonality visible, Q1 is weakest quarter
EBITDA margin improved by 30 bps to 18.5% vs 18.2% YoY
METDelivered EBITDA 47.2 Cr at 18.5%, confirmed. But cost inflation noted on grain/fuel/labor; full-year 23-24% margin guidance unproven amid Q1 cost investments
Branded alco-bev premium segment grew 47.3% to 82.3 Cr
METConfirmed 47.3% growth; but driven by Whistler (lower margin) growing 60%, not just high-margin Indri (18-20% growth). Portfolio mix deteriorating for margins
Chhattisgarh capacity expansion resolves supply constraints
MISSChhattisgarh came online only 15 days in Q1, contributed 5 Cr revenue. Running at ~50% utilization expected by year-end. Chennai ethanol court order blocking orders until Q2/Q3
FY27 60-70% growth guidance is ambitious and achievable
OVERSTATEDQ1 grew 18% YoY. To hit 60% for FY, H2 needs 200+ Cr revenue. Prior guidance claimed 550-700 Cr incremental from new capacity; Chhattisgarh slow ramp limits this
Earnings quality
What changed since the last call
Guidance reaffirmed, not raised
MaintainedQ4 FY26 call guided 60-70% branded alco-bev growth FY27; this call states 'which is what we had indicated when we had done the Q4 call.' EBITDA 23-24% guidance was also 23% last year; no upgrade
Margin improvement slower than prior capex narrative
DowngradeExpansions were supposed to deliver margin uplift via Operating leverage. Q1 EBITDA margin +30 bps vs. prior 18.2%; full-year 23-24% is same as last year despite capacity coming online. Cost inflation and mix dilution offsetting gains
Chhattisgarh ramp delayed
DowngradeQ4 FY26 guidance implied rapid ramp; Q1 actual shows only 15 days, 5 Cr revenue, 50% utilization expected by year-end (not 90%+). Chennai ethanol court order added uncertainty
Branded alco-bev growth led by Whistler, not Indri
NeutralPrior narrative emphasized Indri (Piccadily's crown jewel). Q1 shows Whistler grew 60%+ (lower margin), Indri 18-20% only. Management now frames multi-brand portfolio; margin benefit unclear
The Q&A
Analysts pressed hard on margin dilution from Whistler, ethanol capacity timeline, receivables bloat (170 Cr), and whether 60% growth is IMFL-led or ethanol-dependent. Management defended by citing IMFL brand plurality, but was evasive on individual brand margins and exact Chhattisgarh ethanol/IMFL split. Tone was analytical but somewhat defensive.
Premium alco-bev growth drivers — Ruchika Bhatia, Alchemy Capital
PartialIndri high double-digit, Whistler >60%, Camikara entering CSD. All brands contributing; winter season expected to broaden. Whistler grew faster due to positioning and outlet potential.
Chhattisgarh capacity ramp — Rahil Dasani, MAPL
PartialCourt order delays ethanol orders to Q2/Q3. 50% utilization expected by year-end. Guidance 300-400 Cr intact; IMFL brands to compensate for ethanol shortfall via new launches.
Indri export capacity and long-term scaling — Himanshu Bisani, PinpointX Capital
Answered87,000 barrels (1.6 Cr liters) maturing; can support 8-8.5 lakh cases Indri if all used. Export currently 25%, need to grow 30-40% vs. domestic 20%. Portavadie Scotland distillery (3 years) and international expansion underway.
FY27 revenue growth composition — Rahil Dasani, MAPL
AnsweredIMFL brands (Indri, Whistler, Camikara, Cashmir) will lead, not ethanol. Whistler growing 60%+, new products in Q2/Q3. Ethanol is stopgap capacity fill, not strategic.
EBITDA margin path with Whistler dilution — Rahil Dasani, MAPL
PartialDistillery division EBITDA (ex-sugar) is much higher than 23-24% consolidated. Chhattisgarh margins higher than Indri; branded premium mix shift and H2 revenue scale will compress % cost base.
Malt barrel inventory sustainability — Samarth Pachchigar, GSV
Answered87,000 built over years with mixed ages. Add 60-70 lakh liters/year (last 2 years). No supply constraint foreseen for coming years. New 30 KLPD capacity (up from 12) provides runway.
Export concentration and Indri global strategy — Ishan, HDFC Securities
AnsweredNorth America #1 market. Target: 70% export, 30% domestic (long-term). Main focus: duty-free airport distribution in each market. New geographies being opened, but gradual and deliberate to avoid over-extension.
Cost inflation and margin resilience — Himanshu Bisani, PinpointX Capital
PartialCost up for people and brand investment (new products, distribution). Chhattisgarh only 1 month operations. Investment is front-loaded in Q1; H2 revenue scale will dilute % impact. EBITDA margin will return to prior year or slightly better.
New product pipeline and launch timing — Rahil Dasani, MAPL
PartialLaunches in Q2 and Q3 FY27 (without detail on brand names). This year for priming up; FY28 for robust results. Success of new brands unpredictable due to market dynamics.
Whisky maturation equivalence and Camikara positioning — Aman Vij, Astute Investment
AnsweredCorrect. 1 year India = 3 years Scotland equivalence. All Indian single malts benefit from this quality uplift. Camikara (3-year min cane rum) is premium positioning, category creation underway. Higher-aged versions coming once category matures.
Guidance
FY27 branded alco-bev 60-70% growth (reaffirmed from Q4 FY26)
MediumQ1 showed 47.3% alco-bev growth; H2 seasonality critical. Indri 18-20% growth alone, so Whistler/Camikara/Cashmir ramp must drive 60-70% blended
Company-level ~60% FY27 revenue growth YoY (reaffirmed)
MediumQ1 actual 18.1%; H2 must deliver 200+ Cr (vs ~135 Cr Q1) to achieve 60% full-year. Prior guidance 550-700 Cr incremental from new capacity; actual likely lower due to Chhattisgarh ramp delays
Chhattisgarh 300-400 Cr FY27 revenue (reaffirmed, Q4 guidance)
MediumOnly 5 Cr in Q1 (15 days). Chennai ethanol court order delays orders to Q2/Q3. 50% utilization by year-end noted; implies lower overall contribution
Indri 250-300 Cr incremental (reaffirmed)
HighIndri growing 18-20% on higher base (55+ Cr current); 250-300 Cr incremental implies base is ~280 Cr baseline, achievable
FY27 EBITDA margin 23-24% consolidated (maintained, not raised)
MediumLast year was ~23%; Q1 actual 18.5% (distillery-only basis). Cost inflation (grain, fuel, labor) and mix dilution from lower-margin Whistler creating headwind; full-year consolidation with higher H2 ramp may bridge to 23-24%, but fragile
Distillery division EBITDA margin (ex-sugar) much higher than 23-24%, management claims
LowNot quantified. Management refused to break down brand-level margins. If true, sugar drag is significant; demerger will clarify
No large capex planned FY27; only routine maintenance and upgradation
HighMajor expansions at Indri and Chhattisgarh largely complete. Ongoing: barrel purchases (~1 lakh by year-end) expensed, not capitalized
Risks the call surfaced
Seasonality and revenue concentration
HighQ1 contributes ~35% of annual revenue; H2 60-65% critical. QoQ revenue -24.8% (Q1 vs prior Q4) and PAT -52% show extreme trough. Any H2 shortfall (demand softness, ethanol policy, Chhattisgarh ramp delays) cascades to full-year miss.
Chhattisgarh ramp-up delay
MediumChhattisgarh contributed only 5 Cr in Q1 despite guidance 300-400 Cr FY27. Chennai ethanol court order blocking orders until Q2/Q3. Target 50% utilization by year-end implies lower output. Guidance intact but execution risk high.
Cost inflation and margin pressure
MediumEmployee cost 22 Cr (vs 17 Cr prior), grain and fuel prices surging, distribution and brand investments elevated. EBITDA margin only +30 bps despite revenue growth, showing operational leverage is being offset. Management claims H2 ramp will dilute %, but absolute margin headwind persists.
Premium brand mix execution risk
MediumGrowth driven by Whistler (60%+ growth), Camikara/Cashmir (triple-digit, small base), and new launches. Whistler lower margin than Indri. Camikara/Cashmir success unproven; management admits brand success is 'very subjective' and depends on external factors. New product adoption uncertain.
Malt inventory and capacity constraint risk
Low87,000 filled barrels (1.6 Cr liters) currently maturing; 3-year minimum. If 60-70% growth materializes, inventory depletion could occur by FY28-29. New malt capacity (30 KLPD vs prior 12) ramping, but lags production demand. No visible constraint Q1-FY27, but multi-year runway finite.
Management
Score 7/10. Clear and detailed on operational metrics (malt capacity, facility utilization, export strategy). Evasive on brand-level margins and new product specifics (non-disclosure for competitive reasons credible). Forward guidance reaffirmed rather than updated; transparency on constraints (ethanol court order, cost inflation). Capacity expansions completed on time (Indri, Chhattisgarh). Premiumization strategy validating (47.3% alco-bev growth vs. modest 18% overall revenue). Indri tracked as 13th largest single malt globally. On brand launches: promised Q2-Q3 timing, deferred revenue impact to FY28. Cost management: proactive on grain/fuel hedging, but wage cost ramp (17→22 Cr) suggests aggressive hiring against uncertain near-term demand.
1 · Q2 FY27 (Jul-Sep 2026)
Festive season sales (North India focus); Chhattisgarh ramp-up continues; ethanol policy clarity post-Chennai court
2 · Q3 FY27 (Oct-Dec 2026)
Winter season peak sales; new product launches (2-3 planned for FY27); Chhattisgarh contribution scales
3 · FY27 year-end (Mar 2027)
Full-year guidance verification (60-70% alco-bev growth, 23-24% EBITDA margin); sugar demerger completion
H2 seasonality (60-65% of annual revenue) and cost inflation (grain, fuel, labor) create execution risk.
Piccadily Agro Q1 FY27: consolidated PAT +16% YoY, margins compress
PAT +16.31% YoY · revenue +18.12% · margins compressing
₹270.5 Cr
+18.12% YoY
₹21.44 Cr
+16.31% YoY
7.84%
-0.2pp YoY
₹2.17
Piccadily Agro's consolidated revenue rose 18.1% YoY to ₹270.50 Cr and PAT rose 16.3% YoY to ₹21.44 Cr (EPS ₹2.17 vs ₹1.95), a continuation of last year's growth rather than an inflection. The sequential drop (revenue −24.8% QoQ, PAT −52.0% QoQ from Q4 FY26's ₹359.56 Cr/₹44.70 Cr) is not a demand issue — the company's own notes flag the sugar business as seasonal, and Q1 (Apr-Jun) is its off-season versus Q4's peak crushing/marketing window, so the QoQ swing should not be read as a slowdown.
Q1 FY-2027 vs prior quarters
Consolidated NPM was 7.84% versus 8.02% a year ago and OPM was ~16.2% versus ~16.6% — both roughly flat-to-mildly-compressing YoY, but the margin story sits almost entirely in the segment mix. The core Alco-Bev business (Distillery segment) grew revenue 26.3% YoY to ₹205.66 Cr, but its segment margin (segment result/segment revenue) fell to 20.9% from 23.4% a year ago as finance costs (+0.7%) and depreciation (+94%, capacity coming online) stepped up. The Sugar segment swung to a ₹3.33 Cr operating loss from a ₹4.95 Cr profit a year ago — squarely the seasonal pattern the company flags, not a structural deterioration.
The stock went into the print at ₹778.25, up 8.3% over the past month of trading.
What the summary numbers don't show
No exceptional items this quarter — standalone PAT ₹21.80 Cr (EPS ₹2.21) tracks closely with consolidated, no material standalone/consolidated divergence
Management provided exceptionally strong guidance for FY'27, forecasting 60-70% value growth for the Alco-Bev business, labeling it an 'exceptional year'. This growth is underpinned by the monetization of newly expanded capacity at the Indri and Chhattisgarh plants, which resolves prior supply constraints and is expect
Management's FY27 guidance from the April concall was aggressive: 60-70% value growth for the Alco-Bev business for the full year, ₹550-700 Cr of incremental revenue from newly monetized Indri and Chhattisgarh capacity, and EBITDA margins stable-to-up 50bps. Q1's 26.3% distillery growth and a ~250bps YoY margin decline in that segment both trail that pace — though it is only the first of four quarters against an annual target, and management's own framing points to capacity monetization ramping through the year rather than front-loaded, so this reads as a checkpoint to watch rather than a miss. We found no formal sell-side consensus estimate for this specific quarter (only a generic trailing-growth preview, not a brokerage number), so vs-Street is unknown. On the corporate side, the board that approved this result also called a follow-up meeting for August 18, 2026 to recommend a final dividend, and recommended Rattan Kaur & Associates (the incumbent reviewer) as statutory auditors for five years. Indri picked up a Top-3 placement at the International Whisky Competition 2026 and launched a new travel-retail exclusive ('Ilika') during the quarter — brand-building that supports the premiumization thesis but doesn't show up as a P&L line yet. No management press release was available in the source material for this result.
W1
Distillery segment growth pace: Q1 printed +26.3% YoY versus management's FY27 guide of 60-70% value growth for the business — watch whether H2 capacity ramp at Indri/Chhattisgarh closes the gap
W2
Distillery segment margin: fell to 20.9% from 23.4% YoY this quarter versus management's 'stable or +50bps' FY27 guide — confirm in Q2 whether this reverses
W3
August 18, 2026 board meeting on final dividend recommendation, and progress on the previously flagged sugar-business demerger
Clean typed statement, both columns unambiguous. Consolidated PAT = post-tax profit (₹21.3025 Cr) + ₹0.1332 Cr share of associate profit, matching the same convention used for the prior comparison quarters (PBT−tax alone gives ₹21.30 Cr, not the reported ₹21.44 Cr attributable figure). No exceptional items this quarter (prior periods carried immaterial <₹0.05 Cr items, ignored). Consolidated statement folds in an unreviewed overseas subsidiary with a ₹0.4997 Cr net loss, which auditors call immaterial to the Group.
Real Premiumization, Real Risks: Piccadilly Guides Cautiously Through a Seasonal Trough
Management reaffirmed full-year guidance rather than raising it—despite 47.3% growth in branded spirits. The call reveals why: Chhattisgarh is ramping slower than expected, H2 seasonality (60–65% of annual revenue) is a binary bet, and cost inflation is offsetting margin gains.
₹270.5 Cr
+18.1% YoY | Distillery +26.3% (76% of total)
₹82.3 Cr
+47.3% YoY | 43.5% of distillery revenue (up from 37.8%)
18.5%
+30 bps YoY | Guidance 23–24% (full year)
₹21.4 Cr
+16.3% YoY | Trails revenue; seasonality extreme (QoQ PAT −52%)
The reported numbers look solid on the surface—branded spirits up 47%, distillery up 26%. But management's reaffirmation of full-year guidance, rather than an upgrade, is the tell. The market has already absorbed this: the stock fell 17.52% by day 3 from the pre-result close of ₹778.25, pricing in the real challenges that the call exposed.
Where the premiumization is coming from—and where it's hitting friction
The 47.3% branded alco-bev growth is real. Indri, Piccadilly's anchor single malt (now ranked 13th globally), grew 18–20%, a solid pace for a premium-positioned spirit. But the headline growth is being led by Whistler rum, which grew 60%+ and carries a lower margin than Indri. Camikara and Cashmir, the newer entrants, are also on triple-digit growth trajectories, but from small bases. The portfolio is validating the premiumization thesis—trading up is happening—but the margin quality of that growth is diluted. Management sidestepped analyst questions on individual brand economics, citing competitive sensitivity, but that hedge is itself a signal: the math on Whistler's margin contribution is not as pretty as the headline growth suggests.
On the cost side, the tailwinds from capacity utilization are being offset by structural inflation. Employee costs jumped ₹5 Cr year-on-year (17 Cr to 22 Cr), grain and fuel prices are surging, and distribution investments are elevated to support new launches. The result: EBITDA margin improved only 30 basis points to 18.5% despite the distillery revenue growing 26.3%. That's underwhelming for a quarter where the capex cycle is largely complete and operating leverage should be kicking in hard.
Q1 was a landmark quarter with highest-ever volumes
Revenue ₹270.5 Cr YoY +18.1%, but QoQ −24.8% (seasonal trough, not peak)
Overstated
EBITDA margin improved 30 bps to 18.5% vs. prior 18.2%
Confirmed 18.5%, but full-year 23–24% guidance relies on H2 scale and cost dilution fading
Supported, with caveats
Branded alco-bev grew 47.3% to ₹82.3 Cr
Confirmed, but Whistler (lower-margin) 60%+ growth outpacing Indri (18–20%), diluting margin benefit
Supported, but mix deteriorating
Chhattisgarh capacity expansion resolves supply constraints
Plant online 15 days in Q1, contributed ₹5 Cr; Chennai ethanol court order blocks orders until Q2/Q3; 50% utilization expected by year-end (well short of implied 90%+)
Contradicted
FY27 60–70% alco-bev growth is ambitious and achievable
Q1 delivered 18.1% company-level revenue growth; H2 must deliver 200+ Cr to achieve 60%+ for full year. Prior guidance claimed 550–700 Cr incremental from new capacity; actual likely materially lower
Overstated
What changed on this call
Guidance was maintained, not raised. FY27 branded alco-bev growth of 60–70%, full-year company revenue growth of ~60% YoY, EBITDA margin of 23–24%—all reaffirmed from Q4 FY26. No upgrade. In equity markets, reaffirmation when you have premium growth momentum is often market-code for internal caution about near-term delivery.
On Chhattisgarh, the narrative has clearly shifted. In prior guidance, the expansion was framed as a near-term supply unlock that would drive 300–400 Cr incremental revenue. In this call, it's a multi-quarter ramp. The Chennai ethanol court order is now a material headwind: ethanol orders have been suspended pending policy clarity, expected to resume in Q2–Q3. Chhattisgarh's 15-day operational window in Q1 produced ₹5 Cr revenue; at that run-rate, annualized output is ~₹40 Cr, far short of the 300–400 Cr guidance. Management insists it's intact, but the ramp narrative has compressed.
Finally, the brand portfolio has widened. Indri remains the premium anchor, but Whistler is now the growth engine, and new launches (Camikara, Cashmir, unnamed Q2–Q3 launches) are being framed as portfolio play rather than Indri-centric growth. That's smart strategy—it reduces single-brand risk—but it also softens the margin story. Indri commands premium pricing; Whistler does not.
Premiumization real: 47.3% branded alco-bev growth, Indri 13th global single malt, portfolio diversifying to Whistler/Camikara
Capacity secured: 87,000 filled malt barrels (1.6 Cr liters), 30 KLPD malt facility ramped, supports 4–5 year growth runway without capex
Guidance reaffirmed, not raised, despite premiumization tailwind—signals internal caution on H2 delivery
Cost inflation (employee +₹5 Cr YoY, grain, fuel) offsetting operational leverage; only +30 bps margin improvement despite capex cycle complete
Whistler growth (60%+) outpacing Indri (18–20%), mix shift to lower-margin brand; new product success unproven
Chhattisgarh ramp materially below prior narrative (₹5 Cr in 15 days vs. 300–400 Cr FY27 guidance); ethanol court order adds uncertainty through H2
H2 seasonality (60–65% of annual revenue) creates execution binary; any Q3 shortfall cascades to full-year miss
International expansion (Indri in 31 countries, North America lead market) providing long-term diversification and higher-margin channel
H2 seasonality concentration (60–65% of annual revenue)
HighQ1 shows extreme trough (QoQ revenue −24.8%, PAT −52%). Any Q2–Q3 shortfall—from demand softness, ethanol policy slippage, distribution delays—cascades to a full-year miss and resets guidance credibility.
Chhattisgarh ramp-up below guidance
Medium₹5 Cr in 15 days implies ~₹40 Cr annualized run-rate vs. 300–400 Cr guidance. Chennai ethanol court order delays orders to Q2–Q3. Guidance still intact, but execution risk is real.
Cost inflation and margin resilience
MediumEmployee cost +₹5 Cr YoY (29% jump), grain and fuel surging. Only +30 bps margin improvement despite capex cycle complete. If inflation is structural, not temporary, 23–24% full-year EBITDA guidance is at risk.
Premium brand mix execution (Whistler, Camikara, new launches)
MediumWhistler carries lower margin than Indri but is driving headline growth. New product launches in Q2–Q3 FY27, with FY28 revenue impact deferred. Brand adoption is, per management, 'very subjective' and depends on external factors.
Malt inventory adequacy for accelerated growth
Low87,000 barrels (1.6 Cr liters) with 3-year minimum maturity supports current 4–5 year growth. If 60%+ growth sustains beyond FY28, inventory depletion risk emerges; Portavadie Scotland distillery (3+ years out) provides long-term supply buffer.
1 · H2 order visibility and Chhattisgarh ramp acceleration (Q2–Q3 FY27)
The entire FY27 guidance hinges on 200+ Cr of revenue in H2. Management must deliver on Chhattisgarh IMFL production (post-ethanol court order lift) and demonstrate new product traction. Order books and utilization data will be the litmus test.
2 · New product launches and brand adoption (Q2–Q3, with FY28 revenue impact)
Unnamed launches planned for Q2 and Q3 FY27. Management deferred meaningful revenue contribution to FY28, citing brand success uncertainty. This is the right timeline, but execution risk is high; watch for: channel support, on-trade presence, and early consumer feedback.
3 · Margin trajectory as H2 scale and cost normalization unfold
Can EBITDA margins reach 23–24% despite Whistler's lower-margin growth? Watch for: absolute employee cost stabilization, grain/fuel price trends, and mix contribution (premium alco-bev % of total). If margins compress below 22%, guidance credibility fades.
How the street is positioned
The market has already rendered its verdict. The stock fell 11.03% on day 1 post-result and −17.52% cumulatively by day 3 from the pre-result close of ₹778.25. The move held: as of 2026-08-14, the stock sits at ₹641.9, now 20.72% below its all-time high of ₹809.7 but still 24.64% above the 52-week low of ₹515. It is trading below its SMA20 (₹736.79) and SMA50 (₹665.74) but above its SMA200 (₹607.77), signaling a genuine repricing of medium-term risk without a panic washout.
Technicals reflect selling conviction: RSI at 31.7 (oversold territory) and volume trending upward suggest the sell-off was systematic, not panic-driven—institutions reassessing exposure. FII ownership is essentially flat (0.80%, up 4 bps) and DII marginal (0.88%, up 10 bps); there is no institutional buying into the dip. Promoter ownership remains stable at 68.57%, with no insider selling near the highs.
The market's read aligns with the fundamental picture: a real franchise validating premiumization, but near-term execution risk and H2 binary delivery are real enough to warrant a repricing. The 17.52% haircut reflects a rational recalibration of risk-reward, not a loss-of-faith moment. If H2 delivers on Chhattisgarh ramp and premiumization growth holds, the stock has downside protected by the 23–24% EBITDA margin floor and distillery-level margins that management hints are much higher than consolidated guidance. If H2 misses, the stock could retest the SMA200 and below.
Piccadilly's premiumization thesis is genuine and validated by Q1 execution. But the quarter also exposed the real constraints: Chhattisgarh is slower to ramp than prior narrative suggested, seasonal concentration in H2 is extreme, and cost inflation is offsetting the margin benefit of scale. Management's reaffirmation of guidance—rather than an upgrade—reflects internal caution on near-term delivery.
The honest read is neither bull nor bear, but a company executing a real, multi-year strategy (Indri as a global single malt, 87,000 malt barrels securing 4–5 years of growth) while navigating material near-term headwinds (H2 seasonality, cost inflation, Chhattisgarh court-order delays). The stock's 17.52% repricing is rational; any further upside hinges on H2 order flow and margin resilience.
The single number to track from here: H2 revenue. Management needs to deliver 200+ Cr (vs. ~135 Cr in Q1) to hit the 60% full-year growth guidance. That is the binary that resolves the debate.